RecruitingNCT06875414
Breast Cancer and Resilience in Couple
Breast Cancer, Resilience, Quality of Life and Depression in Couples From Diagnosis to 24 Months Later: Prospective Pilot Study
Sponsor
Regina Elena Cancer Institute
Enrollment
40 participants
Start Date
Nov 14, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective pilot study examining the couple's dyadic attitudes from diagnosis to 24 months later when one member is affected by illness and the adaptive strategies the couple employs when stressful events occur.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria6
- Woman diagnosed with stage 1, 2 or 3 breast cancer
- age\> 18 years (patient and partner)
- The partner must have lived with the woman for at least 6 months at diagnosis and treatment
- Patients under treatment at the radiotherapy clinic
- Subjects available and able to answer questionnaires, interviews, and / or participate in focus groups
- Informed consent
Exclusion Criteria1
- Cognitive deficits and / or inability to comply with the provisions of the study
Interventions
BEHAVIORALNursing care model
Describe relation between resilience, quality of life and depression and marital adaptation in the population considered from diagnosis to 24 months later.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06875414
Related Trials
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892139 locations
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT07060807149 locations
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176257 locations
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700234 locations
Longitudinal Body Composition Assessment in Breast Cancer Patients
NCT074728031 location